The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand · Delayed Price · Currency is THB 28.50
0.00 (0.00%)
Sep 4, 2026, 4:35 PM ICT
BKK:KLINIQ Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,270 | 4,708 | 7,150 | 9,240 | 8,525 | - | |
Market Cap Growth | 4.59% | -34.15% | -22.62% | 8.39% | - | - |
Enterprise Value | 6,114 | 4,717 | 7,093 | 8,436 | 8,748 | - |
Last Close Price | 28.50 | 20.21 | 29.17 | 36.31 | 32.58 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.85 | 12.95 | 22.19 | 32.02 | 41.49 | - |
Forward PE | 12.77 | 12.37 | 19.94 | 26.75 | - | - |
PS Ratio | 1.53 | 1.32 | 2.40 | 4.04 | 5.20 | - |
PB Ratio | 3.39 | 2.64 | 4.16 | 5.43 | 5.18 | - |
P/TBV Ratio | 3.41 | 2.66 | 4.18 | 5.44 | 5.19 | - |
P/FCF Ratio | 13.21 | 13.06 | - | 476.45 | 46.80 | - |
P/OCF Ratio | 8.37 | 7.13 | 12.95 | 23.94 | 20.90 | - |
PEG Ratio | 0.85 | 1.26 | 1.01 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.49 | 1.33 | 2.38 | 3.69 | 5.34 | - |
EV/EBITDA Ratio | 7.23 | 7.12 | 12.83 | 15.63 | 26.59 | - |
EV/EBIT Ratio | 10.95 | 9.89 | 17.80 | 24.44 | 34.21 | - |
EV/FCF Ratio | 12.88 | 13.08 | - | 435.00 | 48.02 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.35 | 0.38 | 0.38 | 0.27 | 0.19 | 1.29 |
Debt / EBITDA Ratio | 0.76 | 0.84 | 0.97 | 0.85 | 0.77 | 0.88 |
Debt / FCF Ratio | 1.36 | 1.88 | - | 23.80 | 1.68 | 1.25 |
Net Debt / Equity Ratio | -0.09 | -0.02 | -0.07 | -0.41 | -0.70 | 0.82 |
Net Debt / EBITDA Ratio | -0.24 | -0.06 | -0.22 | -1.31 | -3.52 | 0.64 |
Net Debt / FCF Ratio | -0.35 | -0.11 | 6.12 | -36.46 | -6.36 | 0.79 |
Asset Turnover | 1.24 | 1.10 | 1.00 | 0.84 | 0.96 | 1.20 |
Inventory Turnover | 5.70 | 5.36 | 6.23 | 6.75 | 7.01 | 4.18 |
Quick Ratio | 0.74 | 0.72 | 0.91 | 1.54 | 2.08 | 0.16 |
Current Ratio | 1.23 | 1.21 | 1.32 | 1.93 | 2.38 | 0.41 |
Return on Equity (ROE) | 23.52% | 20.81% | 18.84% | 17.24% | 22.75% | 95.13% |
Return on Assets (ROA) | 10.51% | 9.24% | 8.35% | 7.94% | 9.39% | 12.07% |
Return on Invested Capital (ROIC) | 26.45% | 22.58% | 25.35% | 38.38% | 54.87% | 43.89% |
Return on Capital Employed (ROCE) | 23.90% | 20.60% | 17.70% | 16.60% | 13.60% | 48.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.74% | 7.72% | 4.51% | 3.12% | 2.41% | - |
FCF Yield | 7.57% | 7.66% | -0.27% | 0.21% | 2.14% | - |
Dividend Yield | 5.09% | 7.17% | 4.80% | 3.58% | 1.54% | - |
Payout Ratio | 75.54% | 87.71% | 95.60% | 80.04% | 74.55% | 61.89% |
Buyback Yield / Dilution | - | - | - | -29.64% | -6.06% | - |
Total Shareholder Return | 5.09% | 7.17% | 4.80% | -26.06% | -4.53% | - |